CDC Website CDC Website

To Join the NPIN community or

You are here

Researchers

HIV Pre-exposure Prophylaxis (PrEP) Implementation Science in CDC-funded Public Health Demonstration Projects (Admin Supp)

NPIN admin's picture
NIMH calls for FY16 administrative supplements that would conduct implementation science research related to a Centers for Disease Control and Prevention (CDC)-funded public health initiative to reduce HIV infections in men who have sex with men (MSM) and transgender individuals through improved HIV pre-exposure prophylaxis (PrEP) planning, outreach, and delivery. Applicants are required to establish collaborative partnerships with Public Health Departments conducting PrEP demonstration projects funded through CDC Funding Opportunity Announcement CDC-RFA-PS15-1506 (CDC Project PrIDE).

Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R21)

NPIN admin's picture
This funding opportunity announcement invites research grant applications focused on: identifying HIV-1-infected cells in the central nervous system (CNS) compartment that are latently infected; developing strategies for targeting these latently infected cells; and aiming to achieve viral silencing leading to inhibition of viral production, without the need for pro-viral reactivation.

Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R01)

NPIN admin's picture
This funding opportunity announcement invites research grant applications focused on: identifying HIV-1-infected cells in the central nervous system (CNS) compartment that are latently infected; developing strategies for targeting these latently infected cells; and aiming to achieve viral silencing leading to inhibition of viral production, without the need for pro-viral reactivation.

Advancing HIV Therapeutic Vaccine Science (U01)

NPIN admin's picture
This Funding Opportunity Announcement (FOA) solicits applications that will advance understanding of vaccine regimens and immune responses that sustainably suppress viral loads in HIV-infected individuals. Applications should propose small, multi-arm, comparative clinical trials designed to identify correlations between levels of induced immune response and HIV virologic control. Vaccines may be combined with adjuvants and/or other modifiers of the immune response to HIV.

Prevention Innovation Program III (PIP) (R01)

NPIN admin's picture
The Prevention Innovation Program III (PIP) encourages research applications in Non-vaccine Biomedical Prevention (nBP) research. The PIP is intended to support high-risk/innovative research and development efforts to establish and maintain a sustainable pipeline for the prevention of HIV acquisition/transmission.

Methods for Prevention Packages Program IV

NPIN admin's picture
The purpose of this Funding Opportunity Announcement (FOA) is to promote multidisciplinary research programs that (1) devise optimal HIV prevention packages (combination interventions) for specific populations and (2) perform feasibility and acceptability studies to demonstrate that the proposed prevention package is acceptable to the target population and the study design is appropriate and feasible. This FOA is intended to encourage collaborations between behavioral and biomedical clinical specialists, epidemiologists, mathematical modelers, and clinical research specialists.

Immunity in Neonates and Infants

NPIN admin's picture
This Funding Opportunity Announcement (FOA) invites applications from institutions and organizations to participate in a cooperative research group, focusing on elucidating mechanisms regulating the development and function of the immune system in neonates (0-28 days) and infants (29 days – 12 months), including immune mechanisms triggered by non-pathogenic or pathogenic microbes (including HIV), vaccines, exposure to allergens, or alterations in immune function due to environmental exposures to pollutants.

Services Planning Research in the Appalachian Region to Address Adverse Health Consequences Associated with Increased Opioid ...

NPIN admin's picture
This FOA will support one-year, services planning research grants to develop anepidemiologic understanding of opioid injection drug use, Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) infection risk, and other adverse health consequences of such drug use, in conjunction with determining what resources/programs are currently available for addressing those problems, in any of the 420 Appalachian counties (www.arc.gov/counties).

Pages

Subscribe to RSS - Researchers